Summary
FDA selected participants for the TEMPO pilot, which supports certain digital health-device developers through a collaborative regulatory pathway and specified enforcement-discretion approach.
Healthcare Implications
The pilot provides a concrete FDA pathway for selected AI-enabled digital-health products and may inform future regulatory approaches for such devices.